An international team of researchers has discovered that genes are linked to humans’ ability to resist typhoid fever. This finding is significant in helping to develop personalised therapies for sufferers of typhoid fever, based on an individual’s genetic code.
The research team, jointly led by A*STAR’s Genome Institute of Singapore (GIS) and the Oxford University Clinical Research Unit (OUCRU) in Vietnam had their findings published in the advanced online issue of Nature Genetics.
Typhoid fever is a disease caused by the bacterium Salmonella typhi and is usually contracted through the consumption of contaminated food or water. Most infected individuals recover without any lasting detriment to their health. However, a number of infected individuals are unable to clear the infection, and develop typhoid fever.
An estimated 21 million cases of typhoid fever and 200,000 deaths occur annually worldwide. Without therapy, the illness can last up to four weeks, ending in death in up to 25 percent of cases. Increasing resistance to available antimicrobial agents may result in dramatic increases in case-fatality rates. Epidemics and high endemic disease rates have occurred in the Central Asian Republics, the Indian subcontinent, and across Asia and the Pacific Islands.
The scientists compared the genomic profiles of typhoid patients with healthy individuals from Vietnam and Nepal. They found that a genetic variant mapping near the human leukocyte antigen (HLA) locus showed very strong association with resistance to typhoid fever. This locus is responsible for the general activation of the immune response upon contact with invading bacteria.
Co-lead author and principal investigator at the Human Genetics unit in GIS, Dr Khor Chiea Chuen, co-lead author and principal investigator at the Human Genetics unit in GIS, said, “We were very surprised to observe such strong association between an HLA marker and individual susceptibility to typhoid. Current typhoid vaccines are not completely effective. The resistance allele acts like a ‘natural vaccine’, and this discovery by our team could help direct and focus future studies to make a truly efficacious typhoid vaccine.”
It was found that individuals carrying one copy of the DNA sequence associated with resistance showed up to four-fold protection against typhoid fever, while those carrying two copies of the same DNA sequence almost never contracted typhoid. This observation suggests that the outcome of the body’s effort to successfully clear an infection by Salmonella typhi depends on how bacterial components interact with the body’s HLA to produce a robust immune response.
Dr Sarah Dunstan, co-lead author and Senior Research Fellow at the Nossal Institute of Global Health, University of Melbourne, added, “Typhoid fever remains a considerable health burden in many lower income countries in Asia. Our study is the first large-scale, search for human genes that affect a person’s risk of typhoid. We found that carrying a particular form of the HLA-DRB1 gene provides natural resistance against typhoid. The HLA molecules are in general very important because they are able to recognise invading bacteria and turn on the body’s immune system. If we can understand this natural mechanism of disease resistance, then we can use this knowledge to help inform improved vaccine and therapeutic design.” Dr Dunstan was Senior Scientist at the OUCRU in Vietnam at the time of the study.
Dr Guy Thwaites, Director of OUCRU in Vietnam, said, “This important study shows the value of multi-centre, collaborative clinical infectious diseases research in Asia. Many of the participants were recruited to clinical trials investigating the best treatment regimens for typhoid fever in Vietnam and Nepal. These patients also provided their consent for later genetic testing, therefore the trials were not only able to provide answers to key clinical questions, but also – as this paper demonstrates beautifully – answers to fundamental questions about shared disease susceptibility mechanisms in different populations.”
1. Data from Centers for Disease Control and Prevention: http://www.cdc.gov/nczved/divisions/dfbmd/diseases/typhoid_fever/technical.html
Spanish scientists create a 3-D bioprinter to print human skin
24.01.2017 | Carlos III University of Madrid
Tracking movement of immune cells identifies key first steps in inflammatory arthritis
23.01.2017 | Massachusetts General Hospital
A Swedish-German team of researchers has cleared up a key process for the artificial production of silk. With the help of the intense X-rays from DESY's...
For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.
According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
24.01.2017 | Physics and Astronomy
24.01.2017 | Life Sciences
24.01.2017 | Health and Medicine